Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Aug 17, 2021 |
Director
Trans History: 15
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
Aug 17, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Chief Business Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Chief Business Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400,000 | -- | 400,000 |
Jun 10, 2021 |
Director
Trans History: 19
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
Jun 10, 2021 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
Jun 10, 2021 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
Jun 10, 2021 |
Director
Trans History: 10
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
Jun 10, 2021 |
Director
Trans History: 15
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
Jun 10, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.